ロード中...
Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
BACKGROUND: Long-acting bronchodilators are central in the pharmacological management of patients with chronic obstructive pulmonary disease (COPD). The aim of this systematic review is to provide an overview of the studies evaluating the safety and clinical efficacy of inhaled glycopyrronium bromid...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3461699/ https://ncbi.nlm.nih.gov/pubmed/23055716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S35990 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|